ArticleFrontiers in bioengineering and biotechnology2025
Hyaluronidases improve the hyaluronic acid yield during the fermentation of
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hyaluronic acid (HA), a linear acidic mucopolysaccharide with exceptional biocompatibility, is extensively utilized in pharmaceuticals and cosmetics. Industrial HA production predominantly relies on Streptococcus zooepidemicus fermentation. However, the accumulation of high-molecular-weight (HMW) HA increases broth viscosity, impeding nutrient diffusion and limiting yield. Methods: To address this, four HAases, HHya1, LHya2, SHya3, and EHya4, were expressed and screened for enzymatic activity. we evaluated the strategic addition of hyaluronidases (HAases) to degrade HMW HA during fermentation, thereby reducing viscosity and enhancing productivity. Results: HHya1 and EHya4 exhibited superior expression levels and catalytic efficiency. Purification and functional characterization revealed distinct degradation profiles, HHya1 hydrolyzed HMW HA into saturated tetrasaccharides, while EHya4 generated unsaturated disaccharides. In shake-flask fermentations, supplementation with 1500 U/L EHya4 increased HA titer by 12%, outperforming HHya1. Scaling to bioreactor cultivation with viscosity-controlled HAase dosing further optimized productivity. By administering HAase at intervals corresponding to viscosity thresholds, HA titers reached 10.3 g/L, representing a 14.4% increase over baseline. Conclusion: These findings demonstrate that HAase application alleviates viscosity-associated bottlenecks in S. zooepidemicus fermentations, establishing an optimized process for scalable HA production. This approach balances enzymatic degradation with microbial growth kinetics, offering a practical strategy for industrial HA biosynthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.